Materials and methods relating to cancer diagnosis
CA 2477096 A1 · Owner: Ncc Technology Ventures Pte Limited · Inventors: Ooi, Chia Huey; Aggarwal, Amit; Kun, Yu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a number of genetic identifiers (genesets) which may be used as diagnostic tools to determine the presence or risk of breast cancer in a patient. The invention also provides genesets which may be used to classify a breast tumour cell as to its molecular subgroup. Each of the identified genesets may be used to product customised specific nucleic acid microarrays for use in diagnosis and classification of breast tumour cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 20, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 20, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 20, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.